"Designing Growth Strategies is in our DNA"

U.S. Genetic Testing Market Size, Share, Trends & COVID-19 Impact Analysis, By Technique (PCR, DNA Sequencing, Microarrays, and Others), By Application (Cardiology, Oncology, Pharmacogenomics, Cognitive Dysfunction, Pathogenomics, and Others), By Payer (Public Health Insurance, Private Health Insurance, and Out-of-Pocket), By End-User (Hospitals, and Independent Laboratories) & Forecast, 2020-2027

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI105034

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Regulatory Overview
    2. Overview: Funding Raised by Genetic Testing focused Start-up Companies
    3. Key Industry Developments - Mergers, Acquisitions, and Partnership
    4. Porter’s Five Forces Analysis
    5. SWOT Analysis
    6. Impact of COVID-19 Pandemic on the U.S. Genetic Testing Market
    7. Analysis of Transactions in the Molecular Diagnostic Clinical Laboratory Market
    8. Overview: Personalized Medicine Market Size (USD billion), U.S., 2019
    9. Reimbursement Scenario
  5. U.S. Genetic Testing Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Technique
      1. PCR
      2. DNA Sequencing
      3. Microarrays
      4. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. Cardiology
      2. Oncology
      3. Pharmacogenomics
      4. Cognitive Dysfunction
      5. Pathogenomics
      6. Others
    4. Market Analysis, Insights and Forecast – By Payer
      1. Public Health Insurance
      2. Private Health Insurance
      3. Out-of-Pocket
    5. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Independent Laboratories
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2019)
    2. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based On Availability))
      1. Invitae Corporation
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      2. Ambry Genetics
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      3. BioReference Laboratories, Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      4. Progenity, Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      5. PathemaGX
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      6. Quest Diagnostics Incorporated
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      7. Myriad Genetics, Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      8. Fulgent Genetics
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      9. Burning Rock Biotech Limited
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Regulatory Overview
    2. Overview: Funding Raised by Genetic Testing focused Start-up Companies
    3. Key Industry Developments - Mergers, Acquisitions, and Partnership
    4. Porter’s Five Forces Analysis
    5. SWOT Analysis
    6. Impact of COVID-19 Pandemic on the U.S. Genetic Testing Market
    7. Analysis of Transactions in the Molecular Diagnostic Clinical Laboratory Market
    8. Overview: Personalized Medicine Market Size (USD billion), U.S., 2019
    9. Reimbursement Scenario
  5. U.S. Genetic Testing Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Technique
      1. PCR
      2. DNA Sequencing
      3. Microarrays
      4. Others
    3. Market Analysis, Insights and Forecast – By Application
      1. Cardiology
      2. Oncology
      3. Pharmacogenomics
      4. Cognitive Dysfunction
      5. Pathogenomics
      6. Others
    4. Market Analysis, Insights and Forecast – By Payer
      1. Public Health Insurance
      2. Private Health Insurance
      3. Out-of-Pocket
    5. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Independent Laboratories
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2019)
    2. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based On Availability))
      1. Invitae Corporation
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      2. Ambry Genetics
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      3. BioReference Laboratories, Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      4. Progenity, Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      5. PathemaGX
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      6. Quest Diagnostics Incorporated
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      7. Myriad Genetics, Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      8. Fulgent Genetics
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      9. Burning Rock Biotech Limited
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
Read Less

Table 01: U.S. Genetic Testing Market Revenue (USD Billion) Forecast, By Technique, 2016 - 2027

Table 02:   U.S. Genetic Testing Market Revenue (USD Billion) Forecast, By Application, 2016–2027

Table 03:   U.S. Genetic Testing Market Revenue (USD Billion) Forecast, by Payer, 2016–2027

Table 04:   U.S. Genetic Testing Market Revenue (USD Billion) Forecast, By End User, 2016–2027

U.S. Genetic Testing Market
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (IN PROCESS)
  • 2024
    (IN PROCESS)
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports